We encourage authors to provide detailed information within their submission to facilitate the interpretation and replication of experiments. Authors can upload supporting documentation to indicate the use of appropriate reporting guidelines for health-related
Sample-size estimation
• You should state whether an appropriate sample size was computed when the study was being designed • You should state the statistical method of sample size computation and any required assumptions • If no explicit power analysis was used, you should describe how you decided what sample (replicate) size (number) to use Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission: Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Replicates
The bone marrow, liver, thymus humanized mouse model for HIV-1 infection utilized in this study is an expensive and labor intensive model and thus prevented us from utilizing large numbers of replicate animals for our studies. We included one uninfected control animal (day 0) in order to show that steady state immune reconstitution levels were similar to those of the infected animals at the same time point and that no HIV-1 was detectable prior to infection. We included three animals at early time points because one focus of this study was to evaluate at what stage post-infection HIV-1 can be detected in bone marrow and compare that to the levels of HIV-1 in the bloodstream. We additionally included two HIV-1-infected animals at later timepoints to evaluate HIV-1 pathogenesis in bone marrow at times after establishment of infection. In sum, 5 total animals were infected with HIV-1 and all showed productive infection as biological replicates as compared to uninfected. As mentioned above, these 5 biological replicates could be further subdivided into early time point animals (n=3) and late time point animals (n=2) representing biological replicates. Concerning sample size, we were limited in the number of replicate animals we could generate, infect, and analyze with the methods utilized in our study. As mentioned in the methods section for immunofluorescence image processing "Three volumes were quantified from 1-2 samples for each time point". 
Statistical reporting
• Statistical analysis methods should be described and justified • Raw data should be presented in figures whenever informative to do so (typically when N per group is less than 10) • For each experiment, you should identify the statistical tests used, exact values of N, definitions of center, methods of multiple test correction, and dispersion and precision measures (e.g., mean, median, SD, SEM, confidence intervals; and, for the major substantive results, a measure of effect size (e.g., Pearson's r, Cohen's d) • Report exact p-values wherever possible alongside the summary statistics and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05.
Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
(For large datasets, or papers with a very large number of statistical tests, you may upload a single table file with tests, Ns, etc., with reference to sections in the manuscript.)
Group allocation
• Indicate how samples were allocated into experimental groups (in the case of clinical studies, please specify allocation to treatment method); if randomization was used, please also state if restricted randomization was applied • Indicate if masking was used during group allocation, data collection and/or data analysis Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Additional data files ("source data") • We encourage you to upload relevant additional data files, such as numerical data that are represented as a graph in a figure, or as a summary table • Where provided, these should be in the most useful format, and they can be Individual animals exhibiting human immune cell reconstitution were randomly placed into experimental groups/time points and levels of HIV or immune cells in the blood (Figure 1-figure supplement 1) were not assessed until after sacrifice. At the time of sacrifice, it was not known whether productive infection of each individual animal had been established.
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